A carregar...
Promising response to axitinib rechallenge for metastatic renal cell carcinoma after progression on prior axitinib: report of two cases
With the marked improvement in the prognosis of patients with metastatic renal cell carcinoma (mRCC) in the era of molecularly targeted therapy, sequential therapies using multiple targeted agents have been intensively performed for these patients. Despite being conducted targeting small cohorts, se...
Na minha lista:
| Publicado no: | Int Cancer Conf J |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Japan
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6498296/ https://ncbi.nlm.nih.gov/pubmed/31149509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-017-0313-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|